Advertisement

Index by author

November 01, 1983; Volume 11,Issue 6

A

  1. Adline, J

    1. Evidence for an arene-3,4-oxide as a metabolic intermediate in the meta- and para-hydroxylation of phenytoin in the dog.
      M A Moustafa, M Claesen, J Adline, D Vandervorst and J H Poupaert
      Drug Metabolism and Disposition November 1983, 11 (6) 574-580;

  2. Alley, E G

    1. Tissue disposition, metabolism, and excretion of cis- and trans-5,10-dihydrogen mirex.
      J D Yarbrough, J M Grimley, P I Karl, J E Chambers, R S Case and E G Alley
      Drug Metabolism and Disposition November 1983, 11 (6) 611-614;

  3. Au, W Y

    1. Cytochrome P-450-dependent oxidation of the 17 alpha-ethynyl group of synthetic steroids. D-homoannulation or enzyme inactivation.
      S E Schmid, W Y Au, D E Hill, F F Kadlubar and W Slikker
      Drug Metabolism and Disposition November 1983, 11 (6) 531-536;

B

  1. Bai, S A

    1. Stereochemical composition of propranolol metabolites in the dog using stable isotope-labeled pseudoracemates.
      T Walle, M J Wilson, U K Walle and S A Bai
      Drug Metabolism and Disposition November 1983, 11 (6) 544-549;

  2. Beaune, P

    1. Metabolism of ketotifen by human liver microsomes. In vitro characterization of a tertiary amine glucuronidation.
      J F Le Bigot, T Cresteil, J R Kiechel and P Beaune
      Drug Metabolism and Disposition November 1983, 11 (6) 585-589;

  3. Bickel, M H

    1. Disposition of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. II. Effects of restricting food intake before and after 6-CB administration.
      W R Jondorf, P A Wyss, S Mühlebach and M H Bickel
      Drug Metabolism and Disposition November 1983, 11 (6) 597-601;

  4. Bickers, D R

    1. Age-related changes in benzo(a)pyrene metabolism and epoxide-metabolizing enzyme activities in rat skin.
      H Mukhtar and D R Bickers
      Drug Metabolism and Disposition November 1983, 11 (6) 562-567;

  5. Birnbaum, L S

    1. Disposition of 4,4'-thiobis(6-t-butyl-m-cresol) in rats.
      L S Birnbaum, W C Eastin, L Johnson and H B Matthews
      Drug Metabolism and Disposition November 1983, 11 (6) 537-543;

  6. Blake, J W

    1. Effect of urine pH on urine levels of oxyphenbutazone in racing horses.
      T Houston, T Tobin and J W Blake
      Drug Metabolism and Disposition November 1983, 11 (6) 617-619;

C

  1. Case, R S

    1. Tissue disposition, metabolism, and excretion of cis- and trans-5,10-dihydrogen mirex.
      J D Yarbrough, J M Grimley, P I Karl, J E Chambers, R S Case and E G Alley
      Drug Metabolism and Disposition November 1983, 11 (6) 611-614;

  2. Chambers, J E

    1. Tissue disposition, metabolism, and excretion of cis- and trans-5,10-dihydrogen mirex.
      J D Yarbrough, J M Grimley, P I Karl, J E Chambers, R S Case and E G Alley
      Drug Metabolism and Disposition November 1983, 11 (6) 611-614;

  3. Claesen, M

    1. Evidence for an arene-3,4-oxide as a metabolic intermediate in the meta- and para-hydroxylation of phenytoin in the dog.
      M A Moustafa, M Claesen, J Adline, D Vandervorst and J H Poupaert
      Drug Metabolism and Disposition November 1983, 11 (6) 574-580;

  4. Conney, A H

    1. Effects of betamethasone on the in vitro and in vivo 2-hydroxylation of biphenyl in the rat.
      M S Miller, M T Huang, G M Williams, A M Jeffrey and A H Conney
      Drug Metabolism and Disposition November 1983, 11 (6) 556-561;

  5. Coomes, M W

    1. The mitochondrial metabolism of 1,2-disubstituted hydrazines, procarbazine and 1,2-dimethylhydrazine.
      M W Coomes and R A Prough
      Drug Metabolism and Disposition November 1983, 11 (6) 550-555;

  6. Cresteil, T

    1. Metabolism of ketotifen by human liver microsomes. In vitro characterization of a tertiary amine glucuronidation.
      J F Le Bigot, T Cresteil, J R Kiechel and P Beaune
      Drug Metabolism and Disposition November 1983, 11 (6) 585-589;

D

  1. Della Corte, L

    1. 2,2'-dihydroxy-3,3'-di-t-butyl-5,5'-dimethoxydiphenyl, a new metabolite of 2-t-butyl-4-methoxyphenol in the rat.
      A Guarna, L Della Corte, M G Giovannini, F De Sarlo and G Sgaragli
      Drug Metabolism and Disposition November 1983, 11 (6) 581-584;

  2. De Sarlo, F

    1. 2,2'-dihydroxy-3,3'-di-t-butyl-5,5'-dimethoxydiphenyl, a new metabolite of 2-t-butyl-4-methoxyphenol in the rat.
      A Guarna, L Della Corte, M G Giovannini, F De Sarlo and G Sgaragli
      Drug Metabolism and Disposition November 1983, 11 (6) 581-584;

  3. Dickinson, R G

    1. Identification of p-hydroxyprimidone as a minor metabolite of primidone in rat and man.
      W D Hooper, A M Treston, N W Jacobsen, R G Dickinson and M J Eadie
      Drug Metabolism and Disposition November 1983, 11 (6) 607-610;

E

  1. Eadie, M J

    1. Identification of p-hydroxyprimidone as a minor metabolite of primidone in rat and man.
      W D Hooper, A M Treston, N W Jacobsen, R G Dickinson and M J Eadie
      Drug Metabolism and Disposition November 1983, 11 (6) 607-610;

  2. Eastin, W C

    1. Disposition of 4,4'-thiobis(6-t-butyl-m-cresol) in rats.
      L S Birnbaum, W C Eastin, L Johnson and H B Matthews
      Drug Metabolism and Disposition November 1983, 11 (6) 537-543;

  3. Edsbäcker, S

    1. Metabolic pathways of the topical glucocorticoid budesonide in man.
      S Edsbäcker, S Jönsson, C Lindberg, A Ryrfeldt and A Thalén
      Drug Metabolism and Disposition November 1983, 11 (6) 590-596;

F

  1. Farina, P R

    1. Isolation and characterization of metaproterenol-3-O-sulfate: a conjugate of metaproterenol in human urine.
      T R MacGregor, L Nastasi, P R Farina and J J Keirns
      Drug Metabolism and Disposition November 1983, 11 (6) 568-573;

G

  1. Giovannini, M G

    1. 2,2'-dihydroxy-3,3'-di-t-butyl-5,5'-dimethoxydiphenyl, a new metabolite of 2-t-butyl-4-methoxyphenol in the rat.
      A Guarna, L Della Corte, M G Giovannini, F De Sarlo and G Sgaragli
      Drug Metabolism and Disposition November 1983, 11 (6) 581-584;

  2. Griffeth, L K

    1. Effects of model traumatic injury on hepatic drug metabolism in the rat. I. In vivo antipyrine metabolism.
      L K Griffeth, G M Rosen, C Tschanz and E J Rauckman
      Drug Metabolism and Disposition November 1983, 11 (6) 517-525;

  3. Griffiths, L A

    1. The effects of an experimental hepatitis on the metabolic disposition of 3-o-(+)-[14C]methylcatechin in the rat.
      A M Hackett and L A Griffiths
      Drug Metabolism and Disposition November 1983, 11 (6) 602-606;

  4. Grimley, J M

    1. Tissue disposition, metabolism, and excretion of cis- and trans-5,10-dihydrogen mirex.
      J D Yarbrough, J M Grimley, P I Karl, J E Chambers, R S Case and E G Alley
      Drug Metabolism and Disposition November 1983, 11 (6) 611-614;

  5. Guarna, A

    1. 2,2'-dihydroxy-3,3'-di-t-butyl-5,5'-dimethoxydiphenyl, a new metabolite of 2-t-butyl-4-methoxyphenol in the rat.
      A Guarna, L Della Corte, M G Giovannini, F De Sarlo and G Sgaragli
      Drug Metabolism and Disposition November 1983, 11 (6) 581-584;

H

  1. Hackett, A M

    1. The effects of an experimental hepatitis on the metabolic disposition of 3-o-(+)-[14C]methylcatechin in the rat.
      A M Hackett and L A Griffiths
      Drug Metabolism and Disposition November 1983, 11 (6) 602-606;

  2. Hemberger, J A

    1. Pulmonary absorption of drugs in the neonatal and adult guinea pig.
      J A Hemberger and L S Schanker
      Drug Metabolism and Disposition November 1983, 11 (6) 615-616;

  3. Hill, D E

    1. Cytochrome P-450-dependent oxidation of the 17 alpha-ethynyl group of synthetic steroids. D-homoannulation or enzyme inactivation.
      S E Schmid, W Y Au, D E Hill, F F Kadlubar and W Slikker
      Drug Metabolism and Disposition November 1983, 11 (6) 531-536;

  4. Hooper, W D

    1. Identification of p-hydroxyprimidone as a minor metabolite of primidone in rat and man.
      W D Hooper, A M Treston, N W Jacobsen, R G Dickinson and M J Eadie
      Drug Metabolism and Disposition November 1983, 11 (6) 607-610;

  5. Houston, T

    1. Effect of urine pH on urine levels of oxyphenbutazone in racing horses.
      T Houston, T Tobin and J W Blake
      Drug Metabolism and Disposition November 1983, 11 (6) 617-619;

  6. Huang, M T

    1. Effects of betamethasone on the in vitro and in vivo 2-hydroxylation of biphenyl in the rat.
      M S Miller, M T Huang, G M Williams, A M Jeffrey and A H Conney
      Drug Metabolism and Disposition November 1983, 11 (6) 556-561;

J

  1. Jacobsen, N W

    1. Identification of p-hydroxyprimidone as a minor metabolite of primidone in rat and man.
      W D Hooper, A M Treston, N W Jacobsen, R G Dickinson and M J Eadie
      Drug Metabolism and Disposition November 1983, 11 (6) 607-610;

  2. Jeffrey, A M

    1. Effects of betamethasone on the in vitro and in vivo 2-hydroxylation of biphenyl in the rat.
      M S Miller, M T Huang, G M Williams, A M Jeffrey and A H Conney
      Drug Metabolism and Disposition November 1983, 11 (6) 556-561;

  3. Johnson, L

    1. Disposition of 4,4'-thiobis(6-t-butyl-m-cresol) in rats.
      L S Birnbaum, W C Eastin, L Johnson and H B Matthews
      Drug Metabolism and Disposition November 1983, 11 (6) 537-543;

  4. Jondorf, W R

    1. Disposition of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. II. Effects of restricting food intake before and after 6-CB administration.
      W R Jondorf, P A Wyss, S Mühlebach and M H Bickel
      Drug Metabolism and Disposition November 1983, 11 (6) 597-601;

  5. Jönsson, S

    1. Metabolic pathways of the topical glucocorticoid budesonide in man.
      S Edsbäcker, S Jönsson, C Lindberg, A Ryrfeldt and A Thalén
      Drug Metabolism and Disposition November 1983, 11 (6) 590-596;

K

  1. Kadlubar, F F

    1. Cytochrome P-450-dependent oxidation of the 17 alpha-ethynyl group of synthetic steroids. D-homoannulation or enzyme inactivation.
      S E Schmid, W Y Au, D E Hill, F F Kadlubar and W Slikker
      Drug Metabolism and Disposition November 1983, 11 (6) 531-536;

  2. Karl, P I

    1. Tissue disposition, metabolism, and excretion of cis- and trans-5,10-dihydrogen mirex.
      J D Yarbrough, J M Grimley, P I Karl, J E Chambers, R S Case and E G Alley
      Drug Metabolism and Disposition November 1983, 11 (6) 611-614;

  3. Keirns, J J

    1. Isolation and characterization of metaproterenol-3-O-sulfate: a conjugate of metaproterenol in human urine.
      T R MacGregor, L Nastasi, P R Farina and J J Keirns
      Drug Metabolism and Disposition November 1983, 11 (6) 568-573;

  4. Kiechel, J R

    1. Metabolism of ketotifen by human liver microsomes. In vitro characterization of a tertiary amine glucuronidation.
      J F Le Bigot, T Cresteil, J R Kiechel and P Beaune
      Drug Metabolism and Disposition November 1983, 11 (6) 585-589;

L

  1. Le Bigot, J F

    1. Metabolism of ketotifen by human liver microsomes. In vitro characterization of a tertiary amine glucuronidation.
      J F Le Bigot, T Cresteil, J R Kiechel and P Beaune
      Drug Metabolism and Disposition November 1983, 11 (6) 585-589;

  2. Leibman, K

    1. Stability of drug-metabolizing activities in lyophilized liver and lung microsomal preparations.
      J M Patel, E Ortiz, K T Shiverick and K Leibman
      Drug Metabolism and Disposition November 1983, 11 (6) 620-621;

  3. Lindberg, C

    1. Metabolic pathways of the topical glucocorticoid budesonide in man.
      S Edsbäcker, S Jönsson, C Lindberg, A Ryrfeldt and A Thalén
      Drug Metabolism and Disposition November 1983, 11 (6) 590-596;

M

  1. MacGregor, T R

    1. Isolation and characterization of metaproterenol-3-O-sulfate: a conjugate of metaproterenol in human urine.
      T R MacGregor, L Nastasi, P R Farina and J J Keirns
      Drug Metabolism and Disposition November 1983, 11 (6) 568-573;

  2. Matthews, H B

    1. Disposition of 4,4'-thiobis(6-t-butyl-m-cresol) in rats.
      L S Birnbaum, W C Eastin, L Johnson and H B Matthews
      Drug Metabolism and Disposition November 1983, 11 (6) 537-543;

  3. Miller, M S

    1. Effects of betamethasone on the in vitro and in vivo 2-hydroxylation of biphenyl in the rat.
      M S Miller, M T Huang, G M Williams, A M Jeffrey and A H Conney
      Drug Metabolism and Disposition November 1983, 11 (6) 556-561;

  4. Montgomery, M R

    1. The relationship between paraquat accumulation and covalent binding in rat lung slices.
      T M Sullivan and M R Montgomery
      Drug Metabolism and Disposition November 1983, 11 (6) 526-530;

  5. Moustafa, M A

    1. Evidence for an arene-3,4-oxide as a metabolic intermediate in the meta- and para-hydroxylation of phenytoin in the dog.
      M A Moustafa, M Claesen, J Adline, D Vandervorst and J H Poupaert
      Drug Metabolism and Disposition November 1983, 11 (6) 574-580;

  6. Mühlebach, S

    1. Disposition of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. II. Effects of restricting food intake before and after 6-CB administration.
      W R Jondorf, P A Wyss, S Mühlebach and M H Bickel
      Drug Metabolism and Disposition November 1983, 11 (6) 597-601;

  7. Mukhtar, H

    1. Age-related changes in benzo(a)pyrene metabolism and epoxide-metabolizing enzyme activities in rat skin.
      H Mukhtar and D R Bickers
      Drug Metabolism and Disposition November 1983, 11 (6) 562-567;

N

  1. Nastasi, L

    1. Isolation and characterization of metaproterenol-3-O-sulfate: a conjugate of metaproterenol in human urine.
      T R MacGregor, L Nastasi, P R Farina and J J Keirns
      Drug Metabolism and Disposition November 1983, 11 (6) 568-573;

O

  1. Ortiz, E

    1. Stability of drug-metabolizing activities in lyophilized liver and lung microsomal preparations.
      J M Patel, E Ortiz, K T Shiverick and K Leibman
      Drug Metabolism and Disposition November 1983, 11 (6) 620-621;

P

  1. Patel, J M

    1. Stability of drug-metabolizing activities in lyophilized liver and lung microsomal preparations.
      J M Patel, E Ortiz, K T Shiverick and K Leibman
      Drug Metabolism and Disposition November 1983, 11 (6) 620-621;

  2. Poupaert, J H

    1. Evidence for an arene-3,4-oxide as a metabolic intermediate in the meta- and para-hydroxylation of phenytoin in the dog.
      M A Moustafa, M Claesen, J Adline, D Vandervorst and J H Poupaert
      Drug Metabolism and Disposition November 1983, 11 (6) 574-580;

  3. Prough, R A

    1. The mitochondrial metabolism of 1,2-disubstituted hydrazines, procarbazine and 1,2-dimethylhydrazine.
      M W Coomes and R A Prough
      Drug Metabolism and Disposition November 1983, 11 (6) 550-555;

R

  1. Rauckman, E J

    1. Effects of model traumatic injury on hepatic drug metabolism in the rat. I. In vivo antipyrine metabolism.
      L K Griffeth, G M Rosen, C Tschanz and E J Rauckman
      Drug Metabolism and Disposition November 1983, 11 (6) 517-525;

  2. Rosen, G M

    1. Effects of model traumatic injury on hepatic drug metabolism in the rat. I. In vivo antipyrine metabolism.
      L K Griffeth, G M Rosen, C Tschanz and E J Rauckman
      Drug Metabolism and Disposition November 1983, 11 (6) 517-525;

  3. Ryrfeldt, A

    1. Metabolic pathways of the topical glucocorticoid budesonide in man.
      S Edsbäcker, S Jönsson, C Lindberg, A Ryrfeldt and A Thalén
      Drug Metabolism and Disposition November 1983, 11 (6) 590-596;

S

  1. Schanker, L S

    1. Pulmonary absorption of drugs in the neonatal and adult guinea pig.
      J A Hemberger and L S Schanker
      Drug Metabolism and Disposition November 1983, 11 (6) 615-616;

  2. Schmid, S E

    1. Cytochrome P-450-dependent oxidation of the 17 alpha-ethynyl group of synthetic steroids. D-homoannulation or enzyme inactivation.
      S E Schmid, W Y Au, D E Hill, F F Kadlubar and W Slikker
      Drug Metabolism and Disposition November 1983, 11 (6) 531-536;

  3. Sgaragli, G

    1. 2,2'-dihydroxy-3,3'-di-t-butyl-5,5'-dimethoxydiphenyl, a new metabolite of 2-t-butyl-4-methoxyphenol in the rat.
      A Guarna, L Della Corte, M G Giovannini, F De Sarlo and G Sgaragli
      Drug Metabolism and Disposition November 1983, 11 (6) 581-584;

  4. Shiverick, K T

    1. Stability of drug-metabolizing activities in lyophilized liver and lung microsomal preparations.
      J M Patel, E Ortiz, K T Shiverick and K Leibman
      Drug Metabolism and Disposition November 1983, 11 (6) 620-621;

  5. Slikker, W

    1. Cytochrome P-450-dependent oxidation of the 17 alpha-ethynyl group of synthetic steroids. D-homoannulation or enzyme inactivation.
      S E Schmid, W Y Au, D E Hill, F F Kadlubar and W Slikker
      Drug Metabolism and Disposition November 1983, 11 (6) 531-536;

  6. Sullivan, T M

    1. The relationship between paraquat accumulation and covalent binding in rat lung slices.
      T M Sullivan and M R Montgomery
      Drug Metabolism and Disposition November 1983, 11 (6) 526-530;

T

  1. Thalén, A

    1. Metabolic pathways of the topical glucocorticoid budesonide in man.
      S Edsbäcker, S Jönsson, C Lindberg, A Ryrfeldt and A Thalén
      Drug Metabolism and Disposition November 1983, 11 (6) 590-596;

  2. Tobin, T

    1. Effect of urine pH on urine levels of oxyphenbutazone in racing horses.
      T Houston, T Tobin and J W Blake
      Drug Metabolism and Disposition November 1983, 11 (6) 617-619;

  3. Treston, A M

    1. Identification of p-hydroxyprimidone as a minor metabolite of primidone in rat and man.
      W D Hooper, A M Treston, N W Jacobsen, R G Dickinson and M J Eadie
      Drug Metabolism and Disposition November 1983, 11 (6) 607-610;

  4. Tschanz, C

    1. Effects of model traumatic injury on hepatic drug metabolism in the rat. I. In vivo antipyrine metabolism.
      L K Griffeth, G M Rosen, C Tschanz and E J Rauckman
      Drug Metabolism and Disposition November 1983, 11 (6) 517-525;

V

  1. Vandervorst, D

    1. Evidence for an arene-3,4-oxide as a metabolic intermediate in the meta- and para-hydroxylation of phenytoin in the dog.
      M A Moustafa, M Claesen, J Adline, D Vandervorst and J H Poupaert
      Drug Metabolism and Disposition November 1983, 11 (6) 574-580;

W

  1. Walle, T

    1. Stereochemical composition of propranolol metabolites in the dog using stable isotope-labeled pseudoracemates.
      T Walle, M J Wilson, U K Walle and S A Bai
      Drug Metabolism and Disposition November 1983, 11 (6) 544-549;

  2. Walle, U K

    1. Stereochemical composition of propranolol metabolites in the dog using stable isotope-labeled pseudoracemates.
      T Walle, M J Wilson, U K Walle and S A Bai
      Drug Metabolism and Disposition November 1983, 11 (6) 544-549;

  3. Williams, G M

    1. Effects of betamethasone on the in vitro and in vivo 2-hydroxylation of biphenyl in the rat.
      M S Miller, M T Huang, G M Williams, A M Jeffrey and A H Conney
      Drug Metabolism and Disposition November 1983, 11 (6) 556-561;

  4. Wilson, M J

    1. Stereochemical composition of propranolol metabolites in the dog using stable isotope-labeled pseudoracemates.
      T Walle, M J Wilson, U K Walle and S A Bai
      Drug Metabolism and Disposition November 1983, 11 (6) 544-549;

  5. Wyss, P A

    1. Disposition of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. II. Effects of restricting food intake before and after 6-CB administration.
      W R Jondorf, P A Wyss, S Mühlebach and M H Bickel
      Drug Metabolism and Disposition November 1983, 11 (6) 597-601;

Y

  1. Yarbrough, J D

    1. Tissue disposition, metabolism, and excretion of cis- and trans-5,10-dihydrogen mirex.
      J D Yarbrough, J M Grimley, P I Karl, J E Chambers, R S Case and E G Alley
      Drug Metabolism and Disposition November 1983, 11 (6) 611-614;
Back to top

In this issue

Advertisement